- call +1-201-465-4211
- email sales@mrinsights.biz
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.
Scope of the Report:
Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.
The increasing demand for drug delivery is expected to be the major factor driving the growth of the biologic injectors market over the forecast period. The introduction of disposable and reusable biologic injectors is expected to drive the growth of the biologic injectors market.
North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.
The worldwide market for Biologic Injectors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Biologic Injectors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
BD
Johnson & Johnson
Roche
Schott
Bayer
Nipro
Ompi
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Disposable Biologic Injectors
Reusable Biologic Injectors
Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
There are 15 Chapters to deeply display the global Biologic Injectors market.
Chapter 1, to describe Biologic Injectors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologic Injectors, with sales, revenue, and price of Biologic Injectors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologic Injectors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologic Injectors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologic Injectors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biologic Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Disposable Biologic Injectors
1.2.2 Reusable Biologic Injectors
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BD
2.1.1 Business Overview
2.1.2 Biologic Injectors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BD Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Biologic Injectors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Biologic Injectors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Schott
2.4.1 Business Overview
2.4.2 Biologic Injectors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Schott Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Biologic Injectors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Nipro
2.6.1 Business Overview
2.6.2 Biologic Injectors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Nipro Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ompi
2.7.1 Business Overview
2.7.2 Biologic Injectors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ompi Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Biologic Injectors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Biologic Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologic Injectors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biologic Injectors Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologic Injectors Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologic Injectors Manufacturer Market Share in 2017
3.3.2 Top 6 Biologic Injectors Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biologic Injectors Market Analysis by Regions
4.1 Global Biologic Injectors Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Injectors Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biologic Injectors Revenue and Market Share by Regions (2013-2018)
4.2 North America Biologic Injectors Sales and Growth Rate (2013-2018)
4.3 Europe Biologic Injectors Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Injectors Sales and Growth Rate (2013-2018)
4.5 South America Biologic Injectors Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Injectors Sales and Growth Rate (2013-2018)
5 North America Biologic Injectors by Countries
5.1 North America Biologic Injectors Sales, Revenue and Market Share by Countries
5.1.1 North America Biologic Injectors Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biologic Injectors Revenue and Market Share by Countries (2013-2018)
5.2 United States Biologic Injectors Sales and Growth Rate (2013-2018)
5.3 Canada Biologic Injectors Sales and Growth Rate (2013-2018)
5.4 Mexico Biologic Injectors Sales and Growth Rate (2013-2018)
6 Europe Biologic Injectors by Countries
6.1 Europe Biologic Injectors Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologic Injectors Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biologic Injectors Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biologic Injectors Sales and Growth Rate (2013-2018)
6.3 UK Biologic Injectors Sales and Growth Rate (2013-2018)
6.4 France Biologic Injectors Sales and Growth Rate (2013-2018)
6.5 Russia Biologic Injectors Sales and Growth Rate (2013-2018)
6.6 Italy Biologic Injectors Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biologic Injectors by Countries
7.1 Asia-Pacific Biologic Injectors Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologic Injectors Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biologic Injectors Revenue and Market Share by Countries (2013-2018)
7.2 China Biologic Injectors Sales and Growth Rate (2013-2018)
7.3 Japan Biologic Injectors Sales and Growth Rate (2013-2018)
7.4 Korea Biologic Injectors Sales and Growth Rate (2013-2018)
7.5 India Biologic Injectors Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biologic Injectors Sales and Growth Rate (2013-2018)
8 South America Biologic Injectors by Countries
8.1 South America Biologic Injectors Sales, Revenue and Market Share by Countries
8.1.1 South America Biologic Injectors Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biologic Injectors Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biologic Injectors Sales and Growth Rate (2013-2018)
8.3 Argentina Biologic Injectors Sales and Growth Rate (2013-2018)
8.4 Colombia Biologic Injectors Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biologic Injectors by Countries
9.1 Middle East and Africa Biologic Injectors Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologic Injectors Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biologic Injectors Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biologic Injectors Sales and Growth Rate (2013-2018)
9.3 UAE Biologic Injectors Sales and Growth Rate (2013-2018)
9.4 Egypt Biologic Injectors Sales and Growth Rate (2013-2018)
9.5 Nigeria Biologic Injectors Sales and Growth Rate (2013-2018)
9.6 South Africa Biologic Injectors Sales and Growth Rate (2013-2018)
10 Global Biologic Injectors Market Segment by Type
10.1 Global Biologic Injectors Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologic Injectors Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologic Injectors Revenue and Market Share by Type (2013-2018)
10.2 Disposable Biologic Injectors Sales Growth and Price
10.2.1 Global Disposable Biologic Injectors Sales Growth (2013-2018)
10.2.2 Global Disposable Biologic Injectors Price (2013-2018)
10.3 Reusable Biologic Injectors Sales Growth and Price
10.3.1 Global Reusable Biologic Injectors Sales Growth (2013-2018)
10.3.2 Global Reusable Biologic Injectors Price (2013-2018)
11 Global Biologic Injectors Market Segment by Application
11.1 Global Biologic Injectors Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Ambulatory Surgical Centers Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Biologic Injectors Market Forecast (2018-2023)
12.1 Global Biologic Injectors Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologic Injectors Market Forecast by Regions (2018-2023)
12.2.1 North America Biologic Injectors Market Forecast (2018-2023)
12.2.2 Europe Biologic Injectors Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologic Injectors Market Forecast (2018-2023)
12.2.4 South America Biologic Injectors Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologic Injectors Market Forecast (2018-2023)
12.3 Biologic Injectors Market Forecast by Type (2018-2023)
12.3.1 Global Biologic Injectors Sales Forecast by Type (2018-2023)
12.3.2 Global Biologic Injectors Market Share Forecast by Type (2018-2023)
12.4 Biologic Injectors Market Forecast by Application (2018-2023)
12.4.1 Global Biologic Injectors Sales Forecast by Application (2018-2023)
12.4.2 Global Biologic Injectors Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biologic Injectors Picture
Table Product Specifications of Biologic Injectors
Figure Global Sales Market Share of Biologic Injectors by Types in 2017
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
